Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1991 Jul;75(7):407–410. doi: 10.1136/bjo.75.7.407

Cis-platinum chemotherapy for ocular basal cell carcinoma.

M Morley 1, P T Finger 1, M Perlin 1, L R Weiselberg 1, D S DeBlasio 1
PMCID: PMC1042405  PMID: 1854693

Abstract

We have used intravenous cis-platinum chemotherapy in the treatment of three patients with basal cell carcinoma of the lid extending into the orbit. Cis-platinum chemotherapy caused a reduction in tumour size and thereby delayed surgery in all cases. It allowed for local resection in one case, appeared to delay a patient's exenteration in a second case, and was used prior to radiotherapy in a third case. While not curative, cis-platinum may be useful as an adjuvant to decrease tumour mass prior to local excision and for patients who refuse or must delay exenteration.

Full text

PDF
407

Images in this article

407Image
on p.407
407Image
on p.407
408Image
on p.408
408Image
on p.408
409Image
on p.409
409Image
on p.409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. L., Edwards J. J. Reconstruction by myocutaneous eyelid flaps. Arch Ophthalmol. 1979 Dec;97(12):2358–2362. doi: 10.1001/archopht.1979.01020020574016. [DOI] [PubMed] [Google Scholar]
  2. Becher R., Schütt P., Osieka R., Schmidt C. G. Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II. J Cancer Res Clin Oncol. 1980;96(2):219–222. doi: 10.1007/BF00405506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berman I. J., Mann M. P. Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man. Cancer. 1980 Feb 15;45(4):764–766. doi: 10.1002/1097-0142(19800215)45:4<764::aid-cncr2820450425>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  4. CUTLER N. L., BEARD C. A method for partial and total upper lid reconstruction. Am J Ophthalmol. 1955 Jan;39(1):1–7. doi: 10.1016/0002-9394(55)92646-5. [DOI] [PubMed] [Google Scholar]
  5. Cohen R. J., Cuneo R. A., Cruciger M. P., Jackman A. E. Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. J Clin Oncol. 1983 Jun;1(6):392–393. doi: 10.1200/JCO.1983.1.6.392. [DOI] [PubMed] [Google Scholar]
  6. Fitzpatrick P. J., Thompson G. A., Easterbrook W. M., Gallie B. L., Payne D. G. Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):449–454. doi: 10.1016/0360-3016(84)90023-3. [DOI] [PubMed] [Google Scholar]
  7. Fraunfelder F. T., Zacarian S. A., Wingfield D. L., Limmer B. L. Results of cryotherapy for eyelid malignancies. Am J Ophthalmol. 1984 Feb;97(2):184–188. doi: 10.1016/s0002-9394(14)76088-x. [DOI] [PubMed] [Google Scholar]
  8. Greenway H. T., Cornell R. C., Tanner D. J., Peets E., Bordin G. M., Nagi C. Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol. 1986 Sep;15(3):437–443. doi: 10.1016/s0190-9622(86)70192-8. [DOI] [PubMed] [Google Scholar]
  9. Griffin J. D., Garnick M. B. Eye toxicity of cancer chemotherapy: a review of the literature. Cancer. 1981 Oct 1;48(7):1539–1549. doi: 10.1002/1097-0142(19811001)48:7<1539::aid-cncr2820480713>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  10. Luxenberg M. N., Guthrie T. H., Jr Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. Ophthalmology. 1986 Apr;93(4):504–510. doi: 10.1016/s0161-6420(86)33708-4. [DOI] [PubMed] [Google Scholar]
  11. Luxenberg M. N., Guthrie T. H., Jr Chemotherapy of eyelid and peritorbital tumors. Trans Am Ophthalmol Soc. 1985;83:162–180. [PMC free article] [PubMed] [Google Scholar]
  12. Older J. J., Quickert M. H., Beard C. Surgical removal of basal cell carcinoma of the eyelids utilizing frozen section control. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1975 Sep-Oct;79(5):658–663. [PubMed] [Google Scholar]
  13. Ostrow S., Hahn D., Wiernik P. H., Richards R. D. Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy. Cancer Treat Rep. 1978 Oct;62(10):1591–1594. [PubMed] [Google Scholar]
  14. Peck G. L., DiGiovanna J. J., Sarnoff D. S., Gross E. G., Butkus D., Olsen T. G., Yoder F. W. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol. 1988 Jul;19(1 Pt 2):176–185. doi: 10.1016/s0190-9622(88)70162-0. [DOI] [PubMed] [Google Scholar]
  15. Piel I. J., Meyer D., Perlia C. P., Wolfe V. I. Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep. 1974 Nov-Dec;58(6):871–875. [PubMed] [Google Scholar]
  16. Pippitt C. H., Jr, Muss H. B., Homesley H. D., Jobson V. W. Cisplatin-associated cortical blindness. Gynecol Oncol. 1981 Oct;12(2 Pt 1):253–255. doi: 10.1016/0090-8258(81)90155-4. [DOI] [PubMed] [Google Scholar]
  17. Putterman A. M. Viable composite grafting in eyelid reconstruction. Am J Ophthalmol. 1978 Feb;85(2):237–241. doi: 10.1016/s0002-9394(14)75955-0. [DOI] [PubMed] [Google Scholar]
  18. Ries F., Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis. 1986 Nov;8(5):368–379. doi: 10.1016/s0272-6386(86)80112-3. [DOI] [PubMed] [Google Scholar]
  19. Robinson J. K. Use of a combination of chemotherapy and radiation therapy in the management of advanced basal cell carcinoma of the head and neck. J Am Acad Dermatol. 1987 Nov;17(5 Pt 1):770–774. doi: 10.1016/s0190-9622(87)70261-8. [DOI] [PubMed] [Google Scholar]
  20. Rodriguez-Sains R. S., Robins P., Smith B., Bosniak S. L. Radiotherapy of periocular basal cell carcinomas: recurrence rates and treatment with special attention to the medical canthus. Br J Ophthalmol. 1988 Feb;72(2):134–138. doi: 10.1136/bjo.72.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ryan R. F., Marks M. W. Topical 5-fluorouracil in treatment of carcinoma of nasal floor and nasal alae. Ann Plast Surg. 1988 Jan;20(1):48–54. doi: 10.1097/00000637-198801000-00010. [DOI] [PubMed] [Google Scholar]
  22. Smith B., Obear M. F. Bridge flap technique for reconstruction of large upper lid defects. Trans Am Acad Ophthalmol Otolaryngol. 1967 Nov-Dec;71(6):897–901. [PubMed] [Google Scholar]
  23. Tenzel R. R. Reconstruction of the central one half of an eyelid. Arch Ophthalmol. 1975 Feb;93(2):125–126. doi: 10.1001/archopht.1975.01010020131007. [DOI] [PubMed] [Google Scholar]
  24. Tenzel R. R., Stewart W. B. Eyelid reconstruction by the semicircle flap technique. Ophthalmology. 1978 Nov;85(11):1164–1169. doi: 10.1016/s0161-6420(78)35578-0. [DOI] [PubMed] [Google Scholar]
  25. Torre D. Cryosurgery of basal cell carcinoma. J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):917–929. [PubMed] [Google Scholar]
  26. Waldow S. M., Lobraico R. V., Kohler I. K., Wallk S., Fritts H. T. Photodynamic therapy for treatment of malignant cutaneous lesions. Lasers Surg Med. 1987;7(6):451–456. doi: 10.1002/lsm.1900070602. [DOI] [PubMed] [Google Scholar]
  27. Walsh T. J., Clark A. W., Parhad I. M., Green W. R. Neurotoxic effects of cisplatin therapy. Arch Neurol. 1982 Nov;39(11):719–720. doi: 10.1001/archneur.1982.00510230045013. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES